N/A
Completed N=36
Text My Hypertension BP Meds NOLA
Source: ClinicalTrials.gov NCT05074173 ↗Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcomePrimary: Measure of Quality of Life Assessed by 14-item Center for Disease Control (CDC) Health Related Quality of Life Questioner — 9.11; 6.81 Days
Summary
The specific aims of this research study are to
1. Engage participants with poorly controlled hypertension and medication non-adherence to use simple digital approaches, specifically recurring text-messages to improve medication adherence.
2. Promote participant medication adherence and interaction with telehealth platforms with recurring text reminders on medication schedules and refills, science-based hypertension education content, and communication exchange with their health providers to improve blood pressure.
3. Evaluate the role of social support in helping participants manage their hypertension and control of Cardiovascular disease (CVD) risk factors, including daily blood pressure measurement, changes in participant quality of life, and barriers towards medication adherence, and setting goals for health behaviors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Measure of Quality of Life Assessed by 14-item Center for Disease Control (CDC) Health Related Quality of Life Questioner |
9.11; 6.81 | — |
| SECONDARY Change in Systolic and Diastolic Blood Pressure Done by Investigators |
142.19; 131.69; 81.19; 79.49 | — |
| SECONDARY Self-report Adherence to Medication |
2.19; 1.58 | — |
| SECONDARY Change in Systolic and Diastolic Blood Pressure Done by the Participant |
131.21; 127.00; 78.07; 77.00 | — |
Eligibility Criteria
Inclusion Criteria
- Adults > 18 years of age.
- Speak and read English.
- Diagnosis of stage 1* and 2** hypertension (HTN), taking at least one antihypertensive medication.
- Internet and mobile phone access with two-way texting capability.
- > 1 on 4-item Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4) or similar tool.
- Able to download blood pressure tracking App to mobile phone. (*Stage 1 HTN: 130-139 mmHg or 80-89 mmHg16) (**Stage 2 HTN: 140 mmHg or higher or >90 mmHg16)
Exclusion Criteria
- Having been hospitalized within 6 months of starting the study if the patient has a diagnosis of heart failure, end-stage kidney disease, acute coronary syndrome, or stroke.
- Plans to cancel mobile phone plan within 3 months.
Data sourced from ClinicalTrials.gov (NCT05074173). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.